Income Tax Expense (Benefit) of Gossamer Bio, Inc. from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary: Gossamer Bio, Inc. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 31 Dec 2017 to 30 Sep 2025.
Gossamer Bio, Inc. Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $0.
Gossamer Bio, Inc. annual Income Tax Expense (Benefit) for 2024 was $893,000.
Gossamer Bio, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.
Gossamer Bio, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.
Source SEC data: View on sec.gov

Income Tax Expense (Benefit), Quarterly (USD)

Income Tax Expense (Benefit), YoY Quarterly Change (%)

Income Tax Expense (Benefit), Annual (USD)

Gossamer Bio, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$0	+$1,132,000		01 Jul 2025	30 Sep 2025	10-Q	05 Nov 2025	2025	Q3
Q2 2025	$0	-$4,435,000	-100%	01 Apr 2025	30 Jun 2025	10-Q	05 Aug 2025	2025	Q2
Q3 2024	$1,132,000	-$1,132,000		01 Jul 2024	30 Sep 2024	10-Q	05 Nov 2025	2025	Q3
Q2 2024	$4,435,000	+$4,435,000		01 Apr 2024	30 Jun 2024	10-Q	05 Aug 2025	2025	Q2
Q3 2023	$0			01 Jul 2023	30 Sep 2023	10-Q	07 Nov 2024	2024	Q3
Q2 2023	$0			01 Apr 2023	30 Jun 2023	10-Q	12 Aug 2024	2024	Q2

Period	Value	YoY Chg	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	$893,000	+$893,000	01 Jan 2024	31 Dec 2024	10-K	13 Mar 2025	2024	FY
2023	$0	$0	01 Jan 2023	31 Dec 2023	10-K	13 Mar 2025	2024	FY
2022	$0		01 Jan 2022	31 Dec 2022	10-K	13 Mar 2025	2024	FY
2019	$0	$0	01 Jan 2019	31 Dec 2019	10-K	24 Mar 2020	2019	FY
2018	$0	$0	01 Jan 2018	31 Dec 2018	10-K	24 Mar 2020	2019	FY
2017	$0		01 Jan 2017	31 Dec 2017	10-K	24 Mar 2020	2019	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.